1,883 results on '"Lund, Lars H."'
Search Results
152. Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes - from the ESC-HFA EORP Heart Failure Long-Term Registry
153. Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction
154. Definition, epidemiology, and burden of disease: HFpEF
155. Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality: Insights From the EMPA-REG OUTCOME Trial
156. Cardiac remodelling part 2: clinical, imaging and laboratory findings: a review from the Biomarkers Working Group of the Heart Failure Association of the ESC
157. Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry.
158. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes
159. Sex‐related differences in left ventricular assist device utilization and outcomes: results from the PCHF‐VAD registry
160. How does age affect outcomes after left ventricular assist device implantation: results from the PCHF‐VAD registry
161. Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction
162. Persistent High Burden of Heart Failure Across the Ejection Fraction Spectrum in a Nationwide Setting
163. Association between heart failure quality of care and mortality: a population‐based cohort study using nationwide registries
164. Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS‐HFpEF study
165. A novel echocardiographic estimate of pulmonary vascular resistance employing the hydraulic analogy to Ohm’s law
166. Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions
167. Left Ventricular Assist Devices: From Bridge to Transplant to Destination Therapy
168. The Registry of the International Society for Heart and Lung Transplantation: Thirty-first Adult Lung and Heart–Lung Transplant Report—2014; Focus Theme: Retransplantation
169. The Registry of the International Society for Heart and Lung Transplantation: Seventeenth Official Pediatric Lung and Heart–Lung Transplantation Report—2014; Focus Theme: Retransplantation
170. The Registry of the International Society for Heart and Lung Transplantation: Seventeenth Official Pediatric Heart Transplantation Report—2014; Focus Theme: Retransplantation
171. The Registry of the International Society for Heart and Lung Transplantation: Thirty-first Official Adult Heart Transplant Report—2014; Focus Theme: Retransplantation
172. Congestion in heart failure: a circulating biomarker‐based perspective
173. Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction
174. Diagnosing heart failure with preserved ejection fraction in cardiac amyloidosis or diagnosing cardiac amyloidosis in heart failure with preserved ejection fraction?
175. Citrullination is linked to reduced Ca 2+ sensitivity in hearts of a murine model of rheumatoid arthritis
176. Reply
177. Trajectories in New York Heart Association functional class in heart failure across the ejection fraction spectrum: data from the Swedish Heart Failure Registry
178. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial
179. Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis
180. Use of guideline‐recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence
181. Temporal Trends of Heart Failure Hospitalizations in Cardiology Versus Noncardiology Wards According to Ejection Fraction: 16-Year Data From the SwedeHF Registry
182. Impact analysis of heart failure across European countries: an ESC‐HFA position paper
183. Catheter ablation for patients with atrial fibrillation and heart failure: insights from the Swedish Heart Failure Registry
184. Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter‐Defibrillator Generator Changes
185. Left ventricular ejection fraction as the primary heart failure phenotyping parameter
186. Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension
187. Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology
188. Planned repetitive use of levosimendan for heart failure in cardiology and internal medicine in Sweden
189. Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study
190. Up‐titrating angiotensin‐converting enzyme inhibitors in heart failure: evidence and challenges
191. Optimizing outcomes after heart transplantation
192. Long‐term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long‐Term Registry
193. Screening for heart transplantation and left ventricular assist system: results from the ScrEEning for advanced Heart Failure treatment (SEE‐HF) study
194. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology
195. Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology
196. Predicting Risk in Patients Hospitalized for Acute Decompensated Heart Failure and Preserved Ejection Fraction: The Atherosclerosis Risk in Communities Study Heart Failure Community Surveillance
197. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid‐range, and reduced ejection fraction
198. A comprehensive population‐based characterization of heart failure with mid‐range ejection fraction
199. Association between demographic, organizational, clinical, and socio‐economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry
200. Controller and battery changes due to technical problems related to the HVAD® left ventricular assist device - a single center experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.